Cargando…
Protection by the NDI1 Gene against Neurodegeneration in a Rotenone Rat Model of Parkinson's Disease
It is widely recognized that mitochondrial dysfunction, most notably defects in the NADH-quinone oxidoreductase (complex I), is closely related to the etiology of sporadic Parkinson's disease (PD). In fact, rotenone, a complex I inhibitor, has been used for establishing PD models both in vitro...
Autores principales: | Marella, Mathieu, Seo, Byoung Boo, Nakamaru-Ogiso, Eiko, Greenamyre, J. Timothy, Matsuno-Yagi, Akemi, Yagi, Takao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175531/ https://www.ncbi.nlm.nih.gov/pubmed/18197244 http://dx.doi.org/10.1371/journal.pone.0001433 |
Ejemplares similares
-
No Immune Responses by the Expression of the Yeast Ndi1 Protein in Rats
por: Marella, Mathieu, et al.
Publicado: (2011) -
Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model
por: Barber-Singh, Jennifer, et al.
Publicado: (2010) -
Successful Amelioration of Mitochondrial Optic Neuropathy Using the Yeast NDI1 Gene in a Rat Animal Model
por: Marella, Mathieu, et al.
Publicado: (2010) -
A phenotypic model recapitulating the neuropathology of Parkinson's disease
por: Ferris, Craig F, et al.
Publicado: (2013) -
Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson’s disease models in vitro and vivo
por: Li, Hongzhi, et al.
Publicado: (2022)